Delivery Order SPE2DB22D2206-SPE2DB24FFN83
Award Date
2/9/24
Potential Completion Date
2/12/24
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including CONTRAVE ER 8-90 MG TABLET 120S, with a ceiling value of $4,392.98. The contract type is a delivery order with a firm fixed-price pricing type, and the ultimate completion date is October 17, 2023. This contract award is not designated as a set-aside. Amerisourcebergen...
This federal contract award, valued at $10,701.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a performance period through May 10, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $13,679.56, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,377.10 for the supply of CONTRAVE ER 8-90 MG TABLET 120S pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of December 28, 2023. This contract is a firm fixed price delivery order, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order valued at $28,946.63 issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,757.99, is a firm fixed-price delivery order for CONTRAVE ER 8-90 MG TABLET 120S. The award has an ultimate completion date of February 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under contract SPE2DB20D3103 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $2,922.22 and a completion date of February 23, 2024. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $3,585.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Contrave ER 8-90 mg tablets, a pharmaceutical product, to support military healthcare programs. The award has an ultimate completion date of April 26, 2024 and is structured as a firm-fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $17,331.10, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Contrave ER 8-90 mg tablets. The delivery order, valued at $13,352.03, has a completion date of February 22, 2024. It is a firm-fixed-price contract for the delivery of these pharmaceutical products to support military and veterans' healthcare programs. The contract is not set aside for any specific business category. Amerisourcebergen Drug...